Swiss Pharmaceuticals React to Trump's 39% Tariffs

We are seeing Swiss pharmaceuticals react to the, I feel like it's the tariffs sentiment that's hitting Swiss stocks altogether, but also the drug pricing story from Friday as well. Just walk us through how these drug makers have responded, how much room to manoeuvre they actually have. So firstly, there's a lot of uncertainty still for Swiss pharma companies.So the 39% is not actually going to hit them immediately. They sort of have a short stay of execution in some ways, but at the same time they know tha ...